10 Best Promising Stocks To Invest In Right Now

Investors have always been interested in stocks that pay dividends, but lately, low interest rates on bonds and other fixed-income investments have made solid dividend payers even more valuable. Among the most promising dividend stocks in the market is Cincinnati Financial (NASDAQ: CINF  ) , and one big reason is that it is one of the few exclusive companies to make the list of Dividend Aristocrats. In order to become a member of this elite group, a company must have raised its dividend payouts to shareholders every single year for at least a quarter-century. Only a few dozen stocks manage to make the cut, and those that do tend to stay there for a long time.

Cincinnati Financial is hardly a household name, even among those who generally follow the insurance industry. But with its lines of property and casualty insurance policies, the company has managed to reward investors with more than 50 straight annual dividend increases. Let's take a closer look at Cincinnati Financial to see whether it can sustain its long streak of rewarding dividend payouts to investors.

Best Dow Dividend Stocks To Buy Right Now: Castle Brands Inc. (ROX)

Castle Brands Inc. develops and markets beverage alcohol products. The company provides rum, whiskey, liqueurs, vodka, tequila, and wine. It offers its products under various brands, including Gosling�s Rum, Gosling�s Dark �n Stormy, Jefferson�s, Jefferson�s Reserve and Jefferson's Presidential Select, Jefferson�s Rye, Clontarf, Pallini, Boru, Knappogue Castle Whiskey, Tierras, Celtic Honey, Brady's Irish Cream, Travis Hasse�s Original Pie, Gozio, A. de Fussigny, and CC. The company offers its products through a network of wholesale distributors and state-operated agencies in the United States, Ireland, Great Britain, Northern Ireland, Germany, Canada, South Africa, Bulgaria, France, Russia, Finland, Norway, Sweden, and China, as well as in continental Europe and Latin America. Castle Brands Inc. is based in New York, New York.

Advisors' Opinion:

• [By Roberto Pedone]

  Another stock that's rapidly moving within range of triggering a big breakout trade is Castle Brands (ROX), which develops and markets premium and super-premium brands in the beverage alcohol categories: rum, whiskey, liqueurs, vodka, tequila and fine wine. This stock has been on fire so far in 2013, with shares up huge by 234%.

  If you take a look at the chart for Castle Brands, you'll notice that this stock has been uptrending very strong for the last three months, with shares soaring higher from its low of 30 cents per share to its recent high of 99 cents per share. During that uptrend, shares of ROX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ROX within range of triggering a big breakout trade.

  Market players should now look for long-biased trades in ROX if it manages to break out above some near-term overhead resistance levels at 93 cents per share to its 52-week high at 99 cents per share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 501,958 shares. If that breakout triggers soon, then ROX will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $1.50 to $2 a share.

  Traders can look to buy ROX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at 80 cents to 77 cents per share, or around its 50-day at 70 cents per share. One can also buy ROX off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

10 Best Promising Stocks To Invest In Right Now: Medtronic Inc (MDT)

Medtronic, Inc. (Medtronic), incorporated on April 23, 1957, is engaged in medical technology - alleviating pain, restoring health, and extending life for millions of people worldwide. As of April, 27, 2012, the Company functions in two operating segments that manufacture and sells device-based medical therapies. The Company's operating segments include Cardiac and Vascular Group, which consists of Cardiac Rhythm Disease Management (CRDM) and CardioVascular, and Restorative Therapies Group, which consists of Spinal, Neuromodulation, Diabetes and Surgical Technologies. Medtronic serves hospitals, physicians, clinicians, and patients in more than 120 countries worldwide. The Company's primary customers include hospitals, clinics, third-party health care providers, distributors, and other institutions, including governmental health care programs and group purchasing organizations. In August 2013, Medtronic, Inc. announced the closing of the acquisition of Cardiocom. Effective September 3, 2013, Medtronic Inc acquired a 30% stake in NGC Medical SpA.

Cardiac Rhythm Disease Management

CRDM develops, manufactures, and markets products for the diagnosis, treatment, and management of heart rhythm disorders and heart failure, including implantable devices, leads and delivery systems, products for the treatment of atrial fibrillation (AF), and information systems for the management of patients with CRDM devices. The Company's principal products offered by CRDM business include Implantable Cardiac Pacemakers (Pacemakers), Implantable Cardioverter Defibrillators (ICDs), Implantable Cardiac Resynchronization Therapy Devices (CRT-Ds and CRT-Ps), AF Products, Diagnostics and Monitoring Devices and Patient Management Tools. The Company's pacemaker systems are compatible with certain magnetic resonance imaging (MRI) machines. This includes the Revo MRI SureScan with United States Food and Drug Administration approval and the Advisa and Ensura MRI SureScan models with Conformite Europeene (CE)! Mark approval. Medtronic also continues to market the Adapta product family, which includes the Adapta, Versa, Sensia, and Relia models.

The Medtronic ICDs is the Protecta family with SmartShock technology, including the Lead Integrity Alert, a technology designed to improve the detection of lead fractures. Devices in the ICD family are the Protecta XT, Protecta, Cardia, and Egida models. Medtronic also continues to market the Secura and Maximo II devices. The Medtronic CRT-Ds is the Protecta family with SmartShock technology, including Protecta XT and Protecta, and the CRT-P devices are Consulta and Syncra. Medtronic also continues to market the Consulta, Cardia, Egida, and Maximo II CRT-D devices. In addition to these devices, Medtronic has an offering of left heart leads and delivery catheters with its Attain family of products. The Company's portfolio of AF products includes the Arctic Front Cardiac CryoAblation Catheter designed to treat paroxysmal AF by performing pulmonary vein isolation. The Company also offers the Reveal XT Insertable Cardiac Monitor, which is designed to identify and quantify episodes of AF. The Reveal DX and Reveal XT Insertable Cardiac Monitors devices are used to record the heart's electrical activity before, during, and after transient symptoms such as syncope and palpitations to help provide a diagnosis. It has a number of patient management tools, such as CareLink, Paceart, and CardioSight Service. CareLink enables patients to transmit data from their pacemaker, ICD, CRT-D, or Insertable Cardiac Monitors using a portable monitor that is connected to a standard telephone line or cellular network using the Medtronic M-Link accessory.

The Company competes with St. Jude Medical, Inc., Boston Scientific Corporation, Biotronik, Inc. and Sorin Group.

CardioVascular

CardioVascular is comprised of three businesses: Coronary, Endovascular and Peripheral, and Structural Heart. The Coronary business includes therapies to treat ! coronary ! artery disease (CAD) and hypertension. The products contained within this business include coronary stents and related delivery systems, along with a broad line of balloon angioplasty catheters, guide catheters, guidewires, diagnostic catheters, and accessories. The products offered by its Coronary business include Percutaneous Coronary Intervention (PCI) and Renal Denervation. The Endovascular and Peripheral business is comprised of a range of products and therapies to treat abdominal and thoracic aortic aneurysms and peripheral vascular disease (PVD). The Company's products include endovascular stent graft systems, embolic protection systems, and stent systems for the treatment of narrowed iliac arteries. The products offered by the Company's Endovascular and Peripheral business include Endovascular Stent Grafts and Peripheral Vascular Intervention (PVI). The Structural Heart business offers a range of products and therapies to treat a variety of heart valve disorders. The Company's products include products for the repair and replacement of heart valves, perfusion systems, positioning and stabilization systems for beating heart revascularization surgery, and surgical ablation products. The Company's principal products offered by its Structural Heart business include Heart Valves, Transcatheter Heart Valves, Arrested Heart Surgery, Beating Heart Surgery and Surgical Ablation.

The Company competes with Abbott Laboratories, Boston Scientific, and Johnson & Johnson, Cook, Inc., W. L. Gore & Associates, Inc., Endologix, Inc., C.R. Bard, Inc., Edwards LifeSciences Corporation, St. Jude, Terumo Medical Corporation and Sorin Group.

Spinal

The Company's Spinal business develops, manufactures, and markets a range of medical devices and implants used in the treatment of the spine and musculoskeletal system. The Company's products and therapies treat a range of conditions affecting the spine, including degenerative disc disease, spinal deformity, spinal tumours, fractures ! of the sp! ine, and stenosis. The Company's Spinal business also provides biologic solutions for the dental and orthopedic markets. The Company's Spinal products are used in spinal fusion of both the thoracolumbar region, referring to the mid to lower vertebrae, as well as of the cervical region, or upper spine and neck vertebrae. Products used to treat spinal conditions include rods, pedicle screws, hooks, plates, and interbody devices, as well as biologics products, primarily bone growth substitutes including bone graft extenders and structural allografts such as dowels and wedges. The products offered by the Company's Spinal business include Thoracolumbar Products, Cervical Products and Biologics Products.

The Company competes with DePuy Spine, Inc., Synthes, Inc., Stryker Corporation, NuVasive, Inc., Globus Medical, Inc., Zimmer, Inc., Alphatec Spine, Inc., Orthofix International N.V., Biomet, Inc. and Johnson & Johnson.

Neuromodulation

The Company's Neuromodulation business develops, manufactures, and markets medical devices for the treatment of chronic pain, movement disorders, psychological disorders, and urological, fecal, and gastroenterological disorders. The l products offered by the Company's Neuromodulation business includes Neurostimulators for Chronic Pain, Implantable Drug Delivery Systems, Deep Brain Stimulation (DBS) Systems and Urology, Fecal, & Gastroenterology Devices. The Company's portfolio of products includes the RestoreSensor (rechargeable), with the Company's AdaptiveStim technology, as well as the RestoreULTRA (rechargeable), RestoreADVANCED (rechargeable), and PrimeADVANCED (non-rechargeable) neurostimulation systems. The SynchroMed II Programmable Infusion System delivers small quantities of drug directly into the intrathecal space surrounding the spinal cord. These devices are used to treat chronic, intractable pain and severe spasticity associated with cerebral palsy, multiple sclerosis, spinal cord and traumatic brain injuries, and stroke.

DBS uses a surgically implanted medical device, similar to a cardiac pacemaker, to deliver carefully controlled electrical stimulation to precisely targeted areas in the brain. The Company's family of Activa Neurostimulators for DBS includes Activa SC (single-channel primary cell), Activa PC (dual channel primary cell), and Activa RC (dual channel rechargeable). The Company's therapeutic portfolio for urology and gastroenterology includes the InterStim Therapy System, which treats the symptoms of overactive bladder, urinary retention, and chronic fecal incontinence, and the Enterra Therapy System for the treatment of chronic nausea and vomiting caused by gastroparesis of diabetic or idiopathic origin for drug refractory patients.

The Company's competes with Boston Scientific, St. Jude., Urologix, Inc. and Allergan.

Diabetes

The Company's Diabetes business develops, manufactures, and markets advanced, integrated diabetes management solutions that include insulin pump therapy, continuous glucose monitoring systems, and therapy management software. The products offered by the Company's Diabetes business includes Integrated Diabetes Management Solutions, Professional CGM and CareLink Therapy Management Software. Outside the United States, the Company offers its Paradigm Veo System, an integrated system that includes a Low Glucose Suspend feature that automatically suspends insulin delivery when glucose levels become too low. In the United States, the Company offers the Paradigm Revel System, which incorporates new CGM features, including predictive alerts that can give early warning to people with diabetes so they can take action to prevent dangerous high or low glucose events. Medtronic offers physicians a Professional CGM product called the iPro CGM and iPro2 Professional CGM. The Company offers Web-based therapy management software solutions, including CareLink Personal software for patients and CareLink Pro software, to helps patients and their health care prov! iders con! trol their diabetes.

The Company competes with DexCom, Inc., Insulet Corporation, Johnson & Johnson and Roche Ltd.

Surgical Technologies

The Company's Surgical Technologies business develops, manufactures, and markets products and therapies to treat diseases and conditions of the ear, nose, and throat (ENT) and certain neurological disorders. In addition, the business develops, manufactures, and markets image-guided surgery and intra-operative imaging systems that facilitate surgical planning during precision cranial, spinal, sinus, and orthopedic surgeries. The products offered by the Company's Surgical Technologies business includes ENT, Neurological Technologies, Navigation and Advanced Energy. The ENT products treat diseases and conditions, such as NIM Nerve Monitoring Systems, Fusion ENT Navigation System, Hydrodebrider Endoscopic Sinus Irrigation System, Meniett Device for Meniere's Disease, Pillar Procedure for Snoring and Sleep Apnea, and Repose System for Obstructive Sleep Apnea. The Neurological Technologies products treat certain neurological disorders and conditions, such as Midas Rex Spine Shaver, the Midas Rex MR7 Pneumatic Platform, the Midas Rex Legend EHS High Speed Surgical Drill, the Strata Family of Adjustable Valves for the treatment of Hydrocephalus, Duet External Drainage & Monitoring System, the IPC System, and the Subdural Evacuating Port System.

The Navigation products are used in cranial, spinal, sinus, and orthopedic surgeries, such as the StealthStation S7 Navigation and i7 Integrated Navigation Systems, the O-Arm 2D/3D Surgical Imaging System, and the PoleStar Surgical MRI System. The products make up the Advanced Energy business: PEAK Surgery System, a tissue dissection system that consists of the PEAK PlasmaBlade and the PULSAR Generator and is cleared for use in a variety of settings, including ENT, plastic reconstructive and general surgery; and the Aquamantys System, which uses patented Transcollation technology to ! provide h! aemostatic sealing of soft tissue and bone and is cleared for use in a range of surgical procedures, including orthopedic surgery, spine, solid organ resection and thoracic procedures.

The Company competes with Gyrus ACMI, Stryker Corporation, Johnson & Johnson, Integra LifeSciences Holdings Corporation, BrainLAB, Inc., GE Healthcare, Siemens Medical Solutions USA, Inc., Philips Medical Systems, Covidien and ArthroCare Corporation.

Advisors' Opinion:

• [By Dan Caplinger]

  The impact of the tax, therefore, is much larger. Look at medical-device giant Medtronic (NYSE: MDT  ) , for instance. It doesn't get all of its sales from medical devices, but they make up a substantial portion of its overall business. With a reported profit margin of about 21% and assuming that its profits are evenly distributed across its product lines, imposing a tax of 2.3% would be equivalent to a roughly 11% surtax on Medtronic's income.

• [By Dan Carroll]

  St. Jude's sales slipped again in this area in its most recent quarterly report, falling 8% -- a bad sign for the company considering that CRM revenue makes up the foundation of its sales. Pacemaker sales in particular nosedived, dropping 12%. It isn't any easier across the industry: Boston Scientific (NYSE: BSX  ) , which made the majority of its revenue from cardiac products last year, saw sales in its interventional cardiology and CRM businesses fall 11% and 7%, respectively, at a constant currency in 2012. Rival Medtronic (NYSE: MDT  ) , the largest purely medical device maker on the market, managed to eke out gains in its cardiac and vascular group over the last nine months but still lost 6% in cardiac rhythm disease management sales.

• [By Rich Smith]

  Medtronic (NYSE: MDT  ) is expanding its products for endovascular aortic repair in the U.S. with two new devices: the FDA-approved Endurant II Aorto-Uni-Iliac (AUI) Stent Graft System and the FDA 510(k)-cleared Sentrant Introducer Sheath.

10 Best Promising Stocks To Invest In Right Now: Fiat SpA (FIATY)

Fiat SpA, incorporated in 1906, is engaged principally in the manufacture and sale of automobiles, agricultural and construction equipment and commercial vehicles. It also manufactures other products and systems, principally engines, transmission systems, automotive-related components, metallurgical products and production systems. In addition, it is involved in certain other sectors, including publishing and communications. The Company and its subsidiaries operates approximately in 50 countries. The Company operates under five segments: automobiles, agricultural and construction equipment (CNH-Case New Holland), trucks and commercial vehicles, components and production systems, and other businesses. On 10 June 2009, the Company acquired 20% interest in Chrysler Group LLC. In January 2014, Fiat SpA announced that through its wholly owned subsidiary Fiat North America LLC (FNA) completed its announced acquisition of all of the VEBA Trust�� membership interests in Chrysler Group LLC.

Automobiles

The Company�� automobiles segment designs, develops and sells automobiles, which include Fiat, Alfa Romeo, Lancia, Abarth, Fiat Professional, Maserati and Ferrari. During the year ended December 31, 2009, this segment delivered a total of 2,150,700 passenger cars and light commercial vehicles.

Agricultural and Construction Equipment (CNH-Case New Holland)

The Company�� agricultural and construction equipment segment is engaged in the development of the agricultural and construction equipment industries in Europe and the United States. CNH operates through six brands: Case IH, New Holland Agriculture, Steyr, New Holland Construction, Case Construction and Kobelo. Case IH includes a range of tractors, combines and bailers. New Holland Agriculture�� products include tractors, harvesting equipment and telehandlers. Steyr is the producer of tractors in Austria. New Holland Construction is a producer of construction equipment with a network of 800 dealers an! d more than 2,100 points of sale in 100 countries.

Case Construction sells and provides service support for a range of construction machinery: from loader backhoes to crawler and wheel excavators, from wheel loaders to wheel and crawler skid steer loaders, from articulated dumpers to telescopic handlers. Kobelco produces and sells a range of compact, mid-size and full-size excavators ranging from 1.9 to 88 tons. It owns more than 250 sales outlets located throughout North America.

Truck and Commercial Vehicles

Truck and Commercial Vehicles segment develops, produces and sells a range of trucks and buses under the brands, which include Iveco, Iveco Irisbus, Iveco Astra and Iveco Magirus. Iveco produces a range of light, medium and heavy commercial and industrial vehicles for transportation and distribution of goods. Iveco Irisbus offers a range of vehicles, from minibuses to touring coaches, from urban buses to interurban buses designed to provide a solution to a variety of transportation needs, whether intraurban or interurban.

Iveco Astra produces 2, 3 and 4-axle vehicles for mining and offers over 210 Extra Heavy-Duty models for dump bodies, water and fuel tanks, cement mixers and pumps, drills, mobile service. In addition, it provides rigid dumpers of 14, 28, 32 and 40 tons and articulated dumpers of 25, 30, 35 and 40 tons. Iveco Magirus offers s range of vehicles for situations like fire, floods, earthquakes and explosions. It offers them under the Iveco Magirus, Lohr Magirus, Iveco Special Vehicles and Camiva brands.

Components and Production Systems

The Company�� products under the Components and Production Systems include FPT Powertrain Technologies, Magneti Marelli, Teksid and Comau. FPT Powertrain Technologies provides engines and transmissions. Magneti Marelli designs and produces automotive systems and components: from lighting to engine control systems, from suspensions to electronic systems, from exhaust system! s to comp! onents to the aftermarket and motorsport. Teksid is the producer of grey and nodular iron castings. It manufactures approximately 600 thousand tons of engine blocks, cylinder heads, engine components, transmissions parts, gearboxes and suspensions. Comau makes body welding and assembly robots, and machining and assembly for mechanical systems. It delivers turnkey solution, which includes design, production, installation, production startup and maintenance to the customers.

Other Businesses

The Company�� other businesses includes the contribution from the Company�� publishing businesses, service companies and holding companies.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]

  Andrew Harrer/Bloomberg via Getty Images BERLIN and MILAN -- Fiat Chrysler has denied a magazine report saying it's in merger talks with Volkswagen, while the German carmaker said it had no takeovers on its agenda. Germany's Manager Magazin said Thursday Volkswagen Chairman Ferdinand Piech had held talks with the owners of Fiat Chrysler about buying all or part of the group that was formed this year from the merger of Italian and U.S. carmakers. The magazine cited unnamed company sources. However, a VW spokesman said Europe's biggest carmaker was focused on delivering improvements at its existing operations. "There are currently no [merger and acquisition] projects on the agenda," he said. "We are now focusing on boosting efficiency across the group." The Agnelli family's holding firm Exor, which owns a 30 percent stake in Fiat Chrysler, denied any talks had taken place, as did Fiat Chrysler. Shares in Fiat Chrysler jumped 5 percent to 7.98 euros on the report, but had retreated to stand up 2.2 percent by 1352 GMT (9:52 a.m. Eastern time). VW's stock was 1.8 percent lower. VW Chief Executive Officer Martin Winterkorn said in March the carmaker, though hoarding almost 18 billion euros ($24 billion) in cash, had no plans to expand the group through acquisitions as it was focusing on integrating its 12 brand network. VW has since sealed a 6.7 billion euro buyout of minority shareholders at Swedish truck division Scania to forge a long-planned alliance of its truck brands. The report could suggest "diverging views" between VW's management and the supervisory board about the carmaker's future course, said Arndt Ellinghorst, a London-based analyst at investment researchers ISI Group, at a time when Winterkorn, 67, and Piech, 77, are soon likely to face a debate over succession. Rather than talking about further expansion, top managers at VW -- concerned that profitability gains aren't keeping pace with the company's steadily growing size -- have been pu

• [By WWW.DAILYFINANCE.COM]

  Gene J. Puskar/AP DETROIT -- said its U.S. July auto sales rose 20 percent and that it expected the industry to show an 8 percent increase for the month. Both figures were below analysts' estimates. Nine analysts surveyed by Reuters had expected gains of 25.5 percent for Chrysler and 11 percent for the industry. However, Chrysler said last month was its best July since 2005, with sales of 167,667 vehicles. Gains in U.S. auto sales have been stronger than the overall economy since the recession. Still, the monthly figures also provide an early glimpse into consumer spending. Auto sales dropped to a low of 10.4 million vehicles in 2009 and have risen steadily since, reaching 15.6 million vehicles last year. They are on a pace for about 16.4 million this year, in part because of easier credit and loans of up to 84 months. In a posting on Twitter, Hyundai Motor said its U.S. July sales rose 1.5 percent to 67,011 vehicles, an all-time record for that month. General Motors (GM), which reports sales later Friday morning, is expected to show a gain of 11 percent, according to the analysts surveyed by Reuters. This month Toyota Motor (TM) is expected to nudge Ford Motor (F) for the No. 2 sales spot, behind GM. Analysts expect Toyota sales to rise 11 percent and Ford's to increase 9 percent. Toyota topped Ford in U.S. sales in July 2013, but Ford has held second place for all of last year and so far this year. On Friday in Turin, Italy, where Chrysler parent Fiat is headquartered for now, shareholders are expected to approve a merger that will create Fiat Chrysler Automobiles, to be registered in the Netherlands. Fiat has relied on the resurgence of Chrysler in North America since the No. 3 U.S. automaker's 2009 government-sponsored bankruptcy as Europe's auto sales flagged. Sales of Chrysler's Jeep SUV brand, which Fiat Chrysler sees as a linchpin in its global growth, showed sales up 41 percent in July, while Ram truck sales rose 14 percent. Chrysler bran

• [By WWW.DAILYFINANCE.COM]

  Does the dealer lose money on recalls? Generally, no.

  Labor rates vary by dealer, but at $100 per hour, that would be $150, with another $89.68 for parts, he said, for a total $240. Dealers make a profit on the parts and technician labor, and the work helps pay for other service staff and overhead, Huffines said by email. A service manager at Raymond Chevrolet put the total cost of a Cobalt recall fix from his lot at $260 for GM. GM said the repair took 90 minutes and declined to comment on the cost. Huffines concluded, "Does the dealer lose money on recalls? Generally, no. Does the dealer make a very nice profit on recalls? Generally, no." The biggest cost to GM, Huffines said, was car rentals offered to ignition switch recall customers, which could be $1,000 to $2,500. GM said 83,000 cars had been loaned to customers. Dealers with their own fleets of service cars love the loaner car option. Mike Bowsher, co-chairman of the GM Dealers Executive Board and president of the Carl Black Automotive Group, based in the Atlanta area, said his four stores sold 10 cars in one week to people who came in for recall repairs. Some bought the loaner cars. Meanwhile, his parts and service business has set records three months running, thanks to the chance to upsell customers who might otherwise bypass the dealership for repair work. "I would have never had a shot at that," he said. Recalls, the 'New Normal' A massive recall by Toyota (TM) in 2009 and 2010 had an immediate effect on the Japanese automaker's U.S. sales, in contrast to GM this year. GM's recalls have come at a time when the economy is healthier, and the company has benefited from the fact that the recalls linked to fatalities are from discontinued models, said Kelley Blue Book senior analyst Karl Brauer. There may be a bigger issue, as well: recalls have become commonplace for almost every automaker, turning into "white noise" for consumer, say analysts and dealers alike. Ray Scarpelli said that with
• [By John Rosevear]

  That was the question a lot of people asked after the newly merged Fiat Chrysler Automobiles (NASDAQOTH: FIATY  ) announced in May that the 100-year-old Dodge brand would change course.�

10 Best Promising Stocks To Invest In Right Now: Home Properties Inc. (HME)

Home Properties, Inc. is an independent real estate investment trust. The firm invests in the real estate markets of the United States. It is engaged in the ownership, management, acquisition, rehabilitation and development of residential apartment communities. The firm also invests in townhomes and offices. Home Properties, Inc. was founded in November 1993 and is based in Rochester, New York.

Advisors' Opinion:

• [By Marc Bastow]

  Apartment community real estate investment trust (REIT) Home Properties (HME) raised its quarterly dividend 4.3% to 73 cents per share, payable on Feb. 25 to shareholders of record as of February 13. At a 5% yield, HME is the highest yielder of this week’s list of dividend stocks increasing payouts.
  HME Dividend Yield: 5.00%

10 Best Promising Stocks To Invest In Right Now: EP Energy Corp (EPE)

EP Energy Corporation, incorporated on August 8, 2013, is an independent exploration and production company. The Company is engaged in the acquisition and development of unconventional onshore oil and natural gas properties in the United States. The Company is focused on creating shareholder value through the development of its low-risk drilling inventory located in four core areas: the Eagle Ford Shale (South Texas), the Wolfcamp Shale (Permian Basin in West Texas), the Altamont field in the Uinta Basin in northeastern Utah and the Haynesville Shale (North Louisiana). In its core areas, it has identified approximately 5,200 drilling locations (including 916 drilling locations to which it has attributed proved undeveloped reserves as of September 30, 2013), of which approximately 96% are oil wells. As of September 30, 2013, it had proved reserves of 513 million barrels of oil equivalent (54% oil and 67% liquids) and for the three months ended September 30, 2013, it had average net daily production of 88,149 barrels of oil equivalent per day (45% oil and 54% liquids). During the year ending September 31, 2013, it sold certain of its natural gas properties, including CBM properties located in the Raton, Black Warrior and Arkoma basins, the majority of its Arklatex natural gas properties and its natural gas properties in South Texas. In May 2014, the Company acquired certain producing properties and undeveloped acreage directly offsetting existing Wolfcamp operating areas in Reagan and Crockett Counties in the Southern Midland Basin.

Eagle Ford Shale

The Eagle Ford Shale, located in South Texas, is the unconventional oil plays in the United States. The Eagle Ford formation in La Salle County has up to 125 feet of net thickness, making it some of the prolific acreage in the area. Due to its high carbonate content, the Eagle Ford is also brittle, and delivers high productivity when fractured, with initial 30-day oil equivalent production rates up to 1,100 barrels of oil equivalent! per day.. The Company as of september 30, 2013, has 97,689 net acres in the Eagle Ford, where it has identified 983 drilling locations. As of September 30, 2013, it had six rigs running and it plan to drill 126 wells in 2013 (of which 100 have been drilled through September 30, 2013), representing 58% of its total wells planned in 2013.

Wolfcamp Shale

The Wolfcamp Shale is located in the Permian Basin, which has produced more than 29 billion barrels of oil and 75 trillion cubic feet of gas over the past 90 years and is estimated by industry experts to contain recoverable oil and natural gas reserves exceeding what has already been produced. With oil production of over 880 one thousand barrels per day from over 80,000 wells during the six months ended June 30, 2013, the Permian Basin represented 51% of the crude oil produced in the State of Texas and approximately 17% of the crude oil and condensate produced onshore in the lower 48 United States. As of September 30, 2013, it had three rigs running and it plans to drill 65 wells in 2013 (of which 48 have been drilled through September 30, 2013), representing 30% of its total wells planned in 2013.

Altamont

The Altamont field is located in the Uinta Basin in northeastern Utah. Its operations are primarily focused on developing the Altamont Field Complex (comprised of the Altamont, Bluebell and Cedar Rim fields). It owns 170,523 net (315,272 gross) acres in Duchesne and Uinta Counties, making it the ease owner in the Altamont Field Complex. Its activity is mainly focused on the development of its vertical inventory on 160-acre spacing. The Company has identified an inventory of 1,135 drilling locations (781 vertical and 354 horizontal). The industry is piloting 80-acre vertical downspacing programs in the Wasatch and Green River formations and horizontal development programs in the multiple shale and tight sand intervals. As of September 30, 2013, it had two rigs running and it plans to drill 26 wells in ! 2013 (of w! hich 20 have been drilled through September 30, 2013), representing 12% of its total wells planned in 2013.

Haynesville Shale

Haynesville Shale is located in East Texas and Northern Louisiana. its operations are concentrated primarily in Desoto Parish, Louisiana in the Holly Field. This area is within the core of the Haynesville Shale with net thickness of 114 feet (210 feet gross), resulting in initial 30-day gas equivalent production rates up to 18 million cubic feet per day. As of September 30, 2013, it has identified 190 drilling locations.

Advisors' Opinion:

• [By Matt Jarzemsky var popups = dojo.query(".socialByline .popC"); popups.forEach]

  Rice Energy Inc.(RICE) has rallied 44% since its $1.1 billion January IPO through Thursday. RSP Permian Inc.(RSPP) has gained 42% since debuting the same month. This year�� other E&P IPO, EP Energy Corp.(EPE), is off 1.9% since it went public in January.

10 Best Promising Stocks To Invest In Right Now: ViaSat Inc.(VSAT)

ViaSat, Inc. designs, produces, and markets satellite and other wireless communication, and networking systems for government and commercial customers. The company?s Government Systems segment offers network-centric Internet protocol (IP) based government communications systems, including tactical radio and information distribution systems that enable real-time collection and dissemination of video and data using transmission links between command centers, communications nodes, and air defense systems; information security and assurance products, which enable military and government users to communicate information securely over networks, and that secure data stored on computers and storage devices; and government satellite communication systems, such as portable, mobile, and fixed broadband modems, terminals, network access control systems, and antenna systems. The company?s Commercial Networks segment provides various satellite communication systems and ground networki ng equipment. It offers satellite network infrastructure and ground terminals to access high capacity satellites; antenna systems for terrestrial and satellite applications, such as geo-special imagery, mobile satellite communication, Ka-band gateways, and other multi-band antennas; enterprise very small aperture terminal networks and products; and mobile broadband satellite communication systems. This segment also provides satellite networking systems design and technology development, including the analysis, design, and specification of satellites and ground systems, ASIC and MMIC design and production, and wide area network compression for enterprise networks. The company?s Satellite Services segment provides wholesale and retail satellite-based broadband Internet services, as well as managed network services for the satellite communication systems of its consumer, enterprise, and mobile broadband customers. ViaSat, Inc. was founded in 1986 and is headquartered in Carlsb ad, California.

Advisors' Opinion:

• [By John Udovich]

  Jim Cramer, the host of CNBC�� Mad Money, recently touted ViaSat, Inc (NASDAQ: VSAT) as an in-flight WiFi or satellite communications related play, meaning its worth taking a closer look at the stock along with the performance of small cap in-flight WiFi provider Gogo Inc (NASDAQ: GOGO) and small cap satellite communications firm Iridium Communications Inc (NASDAQ: IRDM). I should mention that I have written about Gogo Inc in the past (Small Cap Gogo Inc (GOGO): Is There Turbulence Ahead? IRDM�and Is In-flight WiFi Stock Gogo, Inc. (GOGO) the Next Iridium?) and Cramer also touched on some of the differences between the in-flight wifi service offerings of both. Cramer also interviewed ViaSat, Inc�� CEO who said they had been waiting for a new satellite to ��isrupt��the market.

10 Best Promising Stocks To Invest In Right Now: Bank of Communications Co Ltd (BKFCF)

Bank of Communications Co., Ltd. is principally engaged in banking and related financial services. The Bank's business is divided into four segments: personal banking, including personal savings, bank card, personal lending, payment and settlement, investment services, insurance services and wealth management; corporate banking, comprised of cash management, supplying chain financing, investment banking, financial institutional banking and asset custody services; international banking, consisting of foreign exchange wealth management, document settlement, remittance and bill services, trade finance and offshore banking, and e-banking, including personal online banking, enterprise online banking, mobile banking, telephone banking and self-help banking. Advisors' Opinion:

• [By MARKETWATCH]

  HONG KONG (MarketWatch) -- Hong Kong stocks opened lower Tuesday, after China's central bank reportedly drained 48 billion yuan ($7.9 billion) from the money market on Tuesday through bond-repurchase agreements. The Hang Seng Index (HK:HSI) moved lower by 0.3%. Banks retreated, as China Merchants Bank Co., (HK:3968) (CIHHF) declined 2.2%, Bank of Communications Co. (HK:3328) (BKFCF) fell 1.6%, China Minsheng Banking Corp. (HK:1988) (CMAKY) lost 1.4%, and China Citic Bank Corporation (HK:998) (CHCJY) dropped 1.2%. China's Dongfeng Motor Group Co. (HK:489) , currently in negotiations to buy a stake in PSA Peugeot Citroen, suspended trading of its H-shares in Hong Kong markets. The state-owned car maker didn't clarify the reason in the announcement. On Monday, the company said in a filing that its commercial-vehicle unit has been served with a request for arbitration by a Brazilian firm, which is seeking damages of approximately 1.67 billion Brazilian reals ($700 million) for Dongfeng's failure to establish a joint venture with the firm. On the mainland, the Shanghai Composite Index (CN:SHCOMP) gave up 0.5% to 2,125.54.

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Hong Kong stocks inched lower early Friday, with mainland Chinese banks and energy shares among the weak spots. The Hang Seng Index (HK:HSI) lost 0.1% to 22,824.44, with the Hang Seng China Enterprises Index down 0.4%, even as the Shanghai Composite (CN:SHCOMP) rose 0.1%. Concerns about the fiscal health of the top mainland lenders loomed again over the shares, with Bank of China Ltd. (HK:3988) (BACHY) down 0.9%, Bank of Communications Co. (HK:3328) (BKFCF) 1.3% lower, and China Construction Bank Corp. (HK:939) (CICHF) off 0.7%. In the energy sector, Cnooc Ltd. (HK:883) (CEO) gave up 0.9% after posting a 17% gain in third-quarter revenue but not reporting its profit for the period. Its peers also lost ground, as China Petroleum & Chemical Corp. (HK:386) (SNP) and PetroChina Co. (HK:857) (PTR) fell 1% apiece. On the upside, China Unicom Hong Kong Ltd. (HK:762) (CHU) added 1.6% after announcing a gain of more than 50% for its quarterly profit compared to a year earlier. Rival China Mobile Ltd. (HK:941

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Hong Kong stocks started modestly lower Thursday, tracking broad weakness in Asia, with mainland Chinese banks mixed after the release of November lending data. The Hang Seng Index (HK:HSI) lost 0.2% to 23,288.02, while the Hang Seng China Enterprises Index fell 0.4%. However, the Shanghai Composite (CN:SHCOMP) added 0.1% to 2,205.39 in choppy trade that saw it swing between positive and negative territory. Mainland Chinese banks saw mixed reaction after data showed new yuan-denominated loans rose to 624.6 billion yuan ($102 billion) in November, more than 100 billion yuan above the year-earlier figure and beating market forecasts of between 560 billion yuan and 580 billion yuan, according to the XInhua news agency. Among the top banks, Bank of China Ltd. (HK:3988) (BACHY) was up 0.3%, Bank of Communications Co. (HK:3328) (BKFCF) rose 0.2%, Agricultural Bank of China Ltd. (HK:1288) (ACGBF) traded flat, and Industrial & Commercial Bank of China Ltd. (HK:1398) (IDCBF) fell 0.6%. Shares of Aluminum Corp. of China Ltd. (HK:2600) (ACH) lost 0.7% after saying it could see a drop of up to 37% in output from a key Peruvian copper mine. Angang Steel Co. (HK:347) (ANGGF)